Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer.

Urinary Calprotectin loses specificity as tumour marker due to sterile leukocyturia associated with bladder cancer.

<h4>Background</h4>Urinary Calprotectin, a mediator of the innate immune system, has been identified as a biomarker in bladder cancer. Our aim was to investigate the association between sterile leukocyturia and urinary Calprotectin in low-grade and high-grade bladder cancer.<h4>Mat...

Full description

Bibliographic Details
Main Authors: Kathrin Bausch, Elisa Roth, Stefan Heinz, David Horst, Susanne Mathia, Tatjana Vlajnic, Lukas Bubendorf, Timm Westhoff, Christian Wetterauer, Hans Helge Seifert, Jan Ebbing
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0213549

Internet

https://doi.org/10.1371/journal.pone.0213549

Similar Items